Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/20/2003WO2003095620A2 Oocyte recording chamber
11/20/2003WO2003095618A2 Identification of dysregulated genes in patients with multiple sclerosis
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095610A2 Directed evolution method of generating enhanced folding polypeptide variants
11/20/2003WO2003095608A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/20/2003WO2003095607A2 Role of p62 in aging-related disease
11/20/2003WO2003095605A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
11/20/2003WO2003095491A2 Antibody screening libraries
11/20/2003WO2003095481A1 Streptococcal superantigens spe-l and spe-m
11/20/2003WO2003095478A1 Thermostable and monoconjugatable gold cluster complexes
11/20/2003WO2003095475A2 Peptide compounds and their use as protease substrates
11/20/2003WO2003094862A2 tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS
11/20/2003WO2003094860A2 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094856A2 1l1rl-1 as a cardiovascular disease marker and therapeutic target
11/20/2003WO2003094847A2 Compositions and methods for identifying antiviral agents
11/20/2003WO2003094844A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003WO2003094841A2 Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
11/20/2003WO2003094838A2 Simple catalytic dna biosensors for ions based on color changes
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094725A1 Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
11/20/2003WO2003094601A1 Identification of soybeans having resistance to phytophthora sojae
11/20/2003WO2003087398A3 Electrochemical detector systems
11/20/2003WO2003084479A3 Large scale methods of producing adenovirus and adenovirus seed stocks
11/20/2003WO2003079999A3 Modulation of angiogenesis through targeting of arginyl transferase (ate1)
11/20/2003WO2003079401A3 Directed assembly of functional heterostructures
11/20/2003WO2003073088A3 Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction
11/20/2003WO2003072807A3 Sterility testing apparatus
11/20/2003WO2003068979A3 System and methods for discriminating an agent
11/20/2003WO2003066895A3 Quantitative methylation detection in dna samples
11/20/2003WO2003062783A3 Light addressable electrochemical detection of duplex structures
11/20/2003WO2003062458A3 Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
11/20/2003WO2003058251A3 Toxicity test
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003050287A3 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
11/20/2003WO2003048768A3 Protein arrays for allelic variants and uses thereof
11/20/2003WO2003048734A3 Detection of matrix metalloproteinase rna in plasma and serum
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003040344A3 Transcription factor stress-related polypeptides and methods of use in plants
11/20/2003WO2003040334A3 Methods for the identification of inhibitors of 4-coumarate-coa ligase expression or activity in plants
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003038093A3 Regulation of human l-serine dehydratase
11/20/2003WO2003035891A3 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
11/20/2003WO2003035842A3 Hybridization control of sequence variation
11/20/2003WO2003033733A3 Process for the detection of chromosomal aberrations in interphase nuclei
11/20/2003WO2003033009A3 Novel drug targets for arthritis
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003029438A3 Identifying agents that prevent palindrome formation and gene amplification
11/20/2003WO2003029273A3 Classification of lung carcinomas using gene expression analysis
11/20/2003WO2003022993A3 Methods for producing ex vivo models for inflammatory disease and uses thereof
11/20/2003WO2003022421A3 Microcolumn-platform based array for high-throughput analysis
11/20/2003WO2003021261A3 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
11/20/2003WO2003020966A3 Surface for the immobilisation of nucleic acids
11/20/2003WO2003020931A3 Sirna knockout assay method and constructs
11/20/2003WO2003020909A3 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
11/20/2003WO2003020898A3 Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003016344A3 Use of lung carcinoma antigen
11/20/2003WO2003012062A3 Animal model with disrupted fgf14 gene
11/20/2003WO2003010331A3 Immobilisation of proteins and electroactive compounds on a sensor surface by means of a hydrophobin coating
11/20/2003WO2003009816A3 Facile detection of polycythemia vera
11/20/2003WO2003008638A3 Sorting and immobilization system for nucleic acids using synthetic bidning systems
11/20/2003WO2003007884A3 Method and reagents for identifying gene targets for treating breast cancer
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002103048A3 Real happy mapping
11/20/2003WO2002102834A3 Synthetic sensor peptide for the detection and/or measurement of kinase or phosphate activity of proteins
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002092847A3 Method for analysing dna of sweetpotato
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088396A3 Reagents and methods for automated in situ or microarray hybridization
11/20/2003WO2002087792A8 Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles
11/20/2003WO2002086084B1 Sequence characteristics of bladder cancer
11/20/2003WO2002086071A3 Cancer-testis antigens
11/20/2003WO2002086051A3 Nucleic acid analysis by mass differentiable oligomers
11/20/2003WO2002083942A3 Method and device for determining and selecting molecule-molecule interactions
11/20/2003WO2002081738A3 System and method for detecting and quantifying nucleic acids using covalent binding
11/20/2003WO2002081678A8 Method of separating alleles
11/20/2003WO2002081642A3 Gene brcc-3 and diagnostic and therapeutic uses thereof
11/20/2003WO2002079489A3 Method of identifying renalgenerative agents using differential gene expression
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002077293A3 Detection of fungal pathogens using the polymerase chain reaction
11/20/2003WO2002077235A3 Intracellular signaling molecules
11/20/2003WO2002077234A3 Compositions and methods relating to colon specific genes and proteins
11/20/2003WO2002072825A3 Human mrp5-like protein
11/20/2003WO2002070703A8 Cell visual characteristic-modifying sequences
11/20/2003WO2002070658A3 Compositions and methods for increasing amino acid absorption in mammals
11/20/2003WO2002066686A8 Feline infectious peritonitis viruses (fipv) diagnosis
11/20/2003WO2002066675A3 Methods for detecting mutations
11/20/2003WO2002064556A8 Complex carbohydrate arrays and methods for the manufacture and uses thereof
11/20/2003WO2002061121A3 Methods of analysis of nucleic acids
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002059370A8 Methods for identifying compounds that modulate disorders related to nitric oxide/cgmp-dependent protein kinase signaling
1 ... 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 ... 3003